Skip to main content

Clearline Capital LP

SEC CIK
0001600136
Latest filing
Aug 14, 2026

NAUT holding history

Nautilus Biotechnology, Inc. in every 13F filed by Clearline Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NAUT overviewAll 13F holders of NAUTFull Q2 2026 holdings

Shares (Q4 2024)
0
Sold out in Q4 2024
Value
$0
% of portfolio
0.0%
Quarters held
14
Since Q2 2021
Holdings of NAUT by Clearline Capital LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20240$00.0%−144,187−100.0%Sold outHolders
Q3 2024144,187$410.9K<0.1%−19,886−12.1%ReducedHolders
Q2 2024164,073$383.9K<0.1%−4,911−2.9%ReducedHolders
Q1 2024168,984$496.8K<0.1%−65,712−28.0%ReducedHolders
Q4 2023234,696$701.7K0.1%−30,207−11.4%ReducedHolders
Q3 2023264,903$837.1K0.1%00.0%UnchangedHolders
Q2 2023264,903$1.03M0.1%00.0%UnchangedHolders
Q1 2023264,903$733.8K0.1%00.0%UnchangedHolders
Q4 2022264,903$476.8K0.1%00.0%UnchangedHolders
Q3 2022264,903$562.0K0.1%+2,543+1.0%AddedHolders
Q2 2022262,360$706.0K0.1%+15,647+6.3%AddedHolders
Q1 2022246,713$1.07M0.1%+18,188+8.0%AddedHolders
Q4 2021228,525$1.18M0.2%+69,395+43.6%AddedHolders
Q3 2021159,130$977.0K0.1%+118,018+287.1%AddedHolders
Q2 202141,112$415.0K0.1%+41,112NewHolders